Novel factor Xa inhibitors: a patent review

Author： de Candia Modesto   Lopopolo Gianfranco   Altomare Cosimo  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.19, Iss.11, 2009-11, pp. : 1535-1580

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review

By Pinto Donald J P   Qiao Jennifer X   Knabb Robert M  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 645-661

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Factor Xa

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 891-895

Informa Healthcare

Access to resources Recommend Favorite

Factor Xa inhibitors

By Al-Obeidi F.   Ostrem J.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. : 931-953

Informa Healthcare

Access to resources Recommend Favorite

Novel Direct Factor IIa and Xa Inhibitors: Mechanisms of Action and Preclinical Studies

By  

Current Clinical Pharmacology, Vol. 7, Iss. 3, 2012-01 ,pp. : 149-165

Bentham Science Publishers

Access to resources Recommend Favorite

Novel nitric oxide synthase inhibitors: a patent review

By Joubert Jacques   Malan Sarel F  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 537-560

Informa Healthcare

Access to resources Recommend Favorite